Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HealthBanks operates one of the world’s largest private/public networks for cord blood, cord tissue, and immune cell banking. It was the first company globally to offer both cord tissue storage with live MSCs and adult immune cell banking. The company does not develop therapeutics directly but enables future clinical use of stored biological materials in advanced therapies such as transplants or CAR-T treatments. Its technologies enable high recovery rates (>97%) of viable stem cells from processed samples. No direct clinical trial results are reported since it functions as a biobank/service provider rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealthBanks.